aPD-L1 recovered from cross-linking without losing its features to interrupt the PD-1/PD-L1 immune checkpoint, and PTX successfully regressed tumor cells while also amplifying ICB efficacy by inducing ICD effect. This evidence concerns the gene CD274 and neoplasm.